UK Business Secretary to set out new takeover rules

13 July 2014
mergers-acquisitions-big

UK Business Secretary Vince Cable is shortly to announce new regulations to deal with foreign takeover of British firms, telling the national broadcaster, the BBC, that any commitments must have no "wiggle room" for companies to evade legal responsibilities during takeovers.

The proposed development comes in the wake of US pharma giant Pfizer’s (NYSE: PFE) failed attempt to acquired smaller rival Anglo-Swedish major AstraZeneca (LSE: AZN), with the Business Secretary saying he wants the new regime overseeing takeovers to also include possible fines for firms which renege on promises made during the deal. Pfizer walked away from the deal, following three rejections of its hostile bid attempts in May, but many observers believe the company will come back to the table after the six-month “no-return” waiting period mandated by current UK takeover regulations.

Tighter “national interest test” also possible

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical